The pharmaceutical industry is on the cusp of its biggest transformation yet. In what many are terming 'Pharma 3.0', it has begun a descent from a focus on manufacturing to a call-for-attention for creating a healthcare ‘ecosystem’ of sorts.
From new patent laws to the ...
Growing And Nurturing An Ad Agency Culture
Phil Talbot resigns as head of ZenithOptimedia Asia-Pacific
DKSH invites Argentinian chef Martin Lippo to demonstrate the magic of molecular dessert-making
Double Helix launches global market research team for APAC
DG rebrands; plans launch of VideoFusion in Asia
To customise your own news feed.
What's in this issue?